학술논문
Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial
Document Type
Article
Author
Source
In Epilepsy & Behavior April 2020 105
Subject
Language
ISSN
1525-5050